Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline A Austin

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemiaElaine Willmore, Sarah L Elliott, Tryfonia Mainou-Fowler, et al.
Nature Communications|September 12, 2014
Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exonsAndrew Best, Katherine James, Caroline Dalgliesh, et al.
Nature Communications|May 27, 2025
Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotectionJan Kubeš, Galina Karabanovich, Anh T Q Cong, et al.
Nature Communications|August 15, 2019
Mutations in topoisomerase IIβ result in a B cell immunodeficiencyLori Broderick, Shawn Yost, Dong Li, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemiaElaine Willmore, Sarah L Elliott, Tryfonia Mainou-Fowler, et al.
Nature Communications|September 12, 2014
Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exonsAndrew Best, Katherine James, Caroline Dalgliesh, et al.
Nature Communications|May 27, 2025
Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotectionJan Kubeš, Galina Karabanovich, Anh T Q Cong, et al.
Nature Communications|August 15, 2019
Mutations in topoisomerase IIβ result in a B cell immunodeficiencyLori Broderick, Shawn Yost, Dong Li, et al.
Pageof 8